Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)

Peer Review reports

Original Submission
2 Oct 2020	Submitted	Original manuscript
20 Jan 2021	Author responded	Author comments - Sébastien THUREAU
Resubmission - Version 2
20 Jan 2021	Submitted	Manuscript version 2
Publishing
21 Jan 2021	Editorially accepted
4 Feb 2021	Article published	10.1186/s12885-021-07828-2

Back to article page